India to Japan: Sertraline Export Trade Route
India has recorded 62 verified shipments of Sertraline exported to Japan, representing a combined trade value of $25.0M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $403.6K USD. The leading Indian exporter is LUPIN LIMITED, which accounts for 99% of total export value with 57 shipments worth $24.7M USD. On the buying side, KYOWA PHARMACEUTICAL IND.CO.,LTD., is the largest importer in Japan with $23.1M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Japan Sertraline corridor is one of India's established pharmaceutical export routes, with 62 shipments documented worth a combined $25.0M USD. The route is dominated by LUPIN LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's sertraline manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $403.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with sertraline's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 21.0%, placing it at rank #3 among India's top sertraline export destinations globally.
On the import side, key buyers of Indian sertraline in Japan include KYOWA PHARMACEUTICAL IND.CO.,LTD.,, KYOWA PHARMACEUTICAL IND CO LIMITED, KYOWA PHARMACEUTICAL IND. CO., LTD and 3 others. KYOWA PHARMACEUTICAL IND.CO.,LTD., is the single largest importer with 40 shipments valued at $23.1M USD.
Route Characteristics
- Average transit19 days
- Peak seasonQ2
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#3
- Annual growth+21.0%
- Demand growth+19.7%
- Regulatory ease81/100
Top 10 Indian Sertraline Exporters to Japan
Showing top 10 of 2 Indian suppliers exporting Sertraline to Japan, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LUPIN LIMITED Avg $433.3K per shipment | 57 | $24.7M | 98.7% |
| 2 | LUPIN LIMITED Avg $65.6K per shipment | 5 | $327.8K | 1.3% |
This table shows the top 10 of 2 Indian companies exporting sertraline to Japan, ranked by total trade value. The listed exporters are: LUPIN LIMITED, LUPIN LIMITED . LUPIN LIMITED is the dominant supplier with 57 shipments worth $24.7M USD, giving it a 99% market share.
Top 10 Sertraline Importers in Japan
Showing top 10 of 6 known buyers in Japan receiving Sertraline shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian sertraline in Japan include KYOWA PHARMACEUTICAL IND.CO.,LTD.,, KYOWA PHARMACEUTICAL IND CO LIMITED, KYOWA PHARMACEUTICAL IND. CO., LTD, KYOWA PHARMACEUTICAL IND.CO.,LTD., , KYOWA PHARMACEUTICAL IND CO LTD, among 6 total buyers. The largest importer is KYOWA PHARMACEUTICAL IND.CO.,LTD.,, accounting for $23.1M USD across 40 shipments — representing 92% of all sertraline imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | KYOWA PHARMACEUTICAL IND.CO.,LTD., | 40 | $23.1M | 92.1% |
| 2 | KYOWA PHARMACEUTICAL IND CO LIMITED | 6 | $594.1K | 2.4% |
| 3 | KYOWA PHARMACEUTICAL IND. CO., LTD | 6 | $532.0K | 2.1% |
| 4 | KYOWA PHARMACEUTICAL IND.CO.,LTD., | 5 | $327.8K | 1.3% |
| 5 | KYOWA PHARMACEUTICAL IND CO LTD | 1 | $278.7K | 1.1% |
| 6 | KYOWA PHARMACEUTICAL IND.CO.LIMITED | 4 | $237.3K | 0.9% |
Top 10 Sertraline Formulations Imported by Japan
Showing top 10 of 20 product formulations shipped on the India to Japan Sertraline route, ranked by trade value
Japan imports a wide range of sertraline formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA : SERTRALINE TABLETS 50MG KYOWA JAPAN (SERTRALINE 50MG) - 1'S — accounts for $19.8M USD across 7 shipments. There are 20 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA : SERTRALINE TABLETS 50MG KYOWA JAPAN (SERTRALINE 50MG) - 1'S | 7 | $19.8M | 79.2% |
| 2 | PHARMA : SERTRALINE TABLETS 25MG KYOWA JAPAN (SERTRALINE 25MG) - 1'S | 13 | $1.5M | 6.1% |
| 3 | PHARMA : SERTRALINE TABLETS 25MG KYOWA J | 4 | $588.8K | 2.4% |
| 4 | PHARMA : SERTRALINE TABLETS 50MG KYOWA J | 3 | $349.3K | 1.4% |
| 5 | PHARMA : SERTRALINE TABLETS 50MG KYOWA J | 3 | $337.4K | 1.3% |
| 6 | SERTRALINE TABLETS 25MG KYOWA JAPAN SERTRALINE TABLETS 25MG OTHERS-MEDICINE PUTUP FOR RETAIL SALE(CIN NO. L24100MH1983P | 2 | $323.6K | 1.3% |
| 7 | PHARMA SERTRALINE TABLETS 50MG KYOWA JAPAN SERTRALINE 50MG 1 S | 1 | $278.7K | 1.1% |
| 8 | PHARMA : SERTRALINE TABLETS 25MG KYOWA JAPAN (SERTRALINE 25MG) - 1'SPCS | 6 | $267.1K | 1.1% |
| 9 | PHARMA : SERTRALINE TABLETS 25MG KYOWA J | 4 | $256.4K | 1.0% |
| 10 | PHARMA : SERTRALINE TABLETS 50MG KYOWA JAPAN (SERTRALINE 50MG) - 1'SPCS | 3 | $206.2K | 0.8% |
Showing top 10 of 20 Sertraline formulations imported by Japan on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 36 shipments. Transit time averages 19 days by sea.
Market Dynamics
India's sertraline exports to Japan are driven primarily by a handful of large-scale manufacturers. LUPIN LIMITED with 57 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Japan benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — LUPIN LIMITED, LUPIN LIMITED — together account for 100% of total trade value on this route. The average shipment value of $403.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pharma : sertraline tablets 25mg kyowa japan (sertraline 25mg) - 1's and pharma : sertraline tablets 25mg kyowa j, suggesting that buyers in Japan tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, KYOWA PHARMACEUTICAL IND.CO.,LTD., is the largest importer with 40 shipments worth $23.1M USD — representing 92% of all sertraline imports from India on this route. A total of 6 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $25.0M
- Avg. Shipment
- $403.6K
- Suppliers
- 2
- Buyers
- 6
- Transit (Sea)
- ~19 days
- Annual Growth
- +21.0%
Related Analysis
Other Sertraline Routes
Unlock the Full India to Japan Sertraline Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 62 shipments on this route.
Frequently Asked Questions — India to Japan Sertraline Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Sertraline to Japan?
The leading Indian exporters of Sertraline to Japan are LUPIN LIMITED, LUPIN LIMITED . LUPIN LIMITED holds the largest market share at approximately 99% of total trade value on this route.
Q What is the total value of Sertraline exports from India to Japan?
India exports Sertraline to Japan worth approximately $25.0M USD across 62 recorded shipments. The average value per shipment is $403.6K USD.
Q Which ports does India use to ship Sertraline to Japan?
The most active port of origin is SAHAR AIR with 36 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Japan for Sertraline?
The average transit time for Sertraline shipments from India to Japan is approximately 19 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Japan Sertraline trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.0% with demand growth tracking at 19.7%. The route is ranked #3 among India's top Sertraline export destinations globally.
Q How many suppliers are active on the India to Japan Sertraline route?
There are currently 2 active Indian suppliers exporting Sertraline to Japan. The market is moderately concentrated with LUPIN LIMITED accounting for 99% of total shipment value.
Q Who are the main importers of Sertraline from India in Japan?
The leading importers of Indian Sertraline in Japan include KYOWA PHARMACEUTICAL IND.CO.,LTD.,, KYOWA PHARMACEUTICAL IND CO LIMITED, KYOWA PHARMACEUTICAL IND. CO., LTD, KYOWA PHARMACEUTICAL IND.CO.,LTD., , KYOWA PHARMACEUTICAL IND CO LTD. KYOWA PHARMACEUTICAL IND.CO.,LTD., is the largest buyer with 40 shipments worth $23.1M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Japan export trade corridor identified from Indian Customs (DGFT) records for Sertraline.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 6 importers in Japan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 62 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
62 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists